prnewswire.com
We’ve assigned a media bias rating of center to prnewswire.com. You can read more about our methodology here.
Information about prnewswire.comWhere is prnewswire.com located?Headquarters: United Statesprnewswire.com's Website
Media Bias Ratings
Does prnewswire.com lean left or right?
Learn more about Media Bias Ratings.
Top prnewswire.com News
Alzheimer · WashingtonThe Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.See the Story
FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial
59% Center coverage: 189 sources
Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Crinetics Pharmaceuticals (NASDAQ:CRNX)
100% Center coverage: 3 sources
BusinessNova expects to release its financial results for the fourth quarter and full year of 2022 before the Nasdaq market opens on February 15, 2023. Eitan Oppenhaim, President and Chief Executive Officer, and Dror David, Chief Financial Officer, will host a conference call to review the Company's financial results. The conference call will be available via a live webcast from a link on Nova's Investor Relations website.See the Story
Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results - Esperion Therapeutics (NASDAQ:ESPR)
67% Center coverage: 3 sources
Latest News Stories
American ExpressThe gross proceeds to the Company from the transaction are $30 million, before deducting estimated transaction-related expenses payable by the Company. Armata intends to use the net proceeds from this transaction to continue clinical development of AP-PA02 and AP-SA02. These funds will finance the completion of an advanced biologics cGMP manufacturing facility with the technology to support production of complex multi- component phage therapeutics.See the Story
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC - Innoviva (NASDAQ:INVA), Armata Pharmaceuticals (AMEX:ARMP)
100% Center coverage: 2 sources
Mercato Partners Acquisition Corporation Signs Letter of Intent for a Business Combination
100% Center coverage: 1 sources
Luokung Receives Nasdaq Listing Determination Company to Request Hearing
100% Center coverage: 1 sources
Steakholder Foods Ltd. Announces Closing of $6.5 Million Public Offering
100% Center coverage: 1 sources
Detroit, Michigan · DetroitIf you purchased Iris Energy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 13, 2023. The Rosen Law Firm represents investors throughout the globe.See the Story
CACC INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Credit Acceptance Corporation Investors to Inquire About Securities Class Action Investigation – CACC - Credit Acceptance (NASDAQ:CACC)
100% Center coverage: 2 sources
Frankfort, Kentucky · FrankfortJay Herratti is CEO and Executive Director of TED Conferences LLC. West Monroe has announced key steps in its growth strategy, including a $250 million investment toward building a global product development platform. "His talent for detecting emerging patterns, capitalizing on disruptive opportunities will be powerful assets for our business as we make bold moves," said Kevin McCarty, West Monroe's chairman and CEO.See the Story
West Monroe Appoints TED CEO Jay Herratti to Board of Directors
Coverage: 2 sources
Outlook on the Nicotine Market in the US to 2027 - Rising Popularity of E-Cigarettes Drives Growth
100% Center coverage: 1 sources
Settlement reached in Dr. Aysha Khoury's lawsuit against the Kaiser Permanente School of Medicine
100% Center coverage: 1 sources